Software Healthcare Sector

BridgeBio Pharma

Market Cap: US$15.1b

A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

DaVita

Market Cap: US$15.1b

Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Cooper Companies

Market Cap: US$14.5b

Develops, manufactures, and markets contact lens wearers.

BrightSpring Health Services

Market Cap: US$14.4b

Operates as a home and community-based healthcare services platform in the United States.

Exelixis

Market Cap: US$14.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Solventum

Market Cap: US$13.6b

A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.

Ionis Pharmaceuticals

Market Cap: US$13.5b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Fisher & Paykel Healthcare

Market Cap: NZ$23.3b

Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.

ICON

Market Cap: US$13.2b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Align Technology

Market Cap: US$13.2b

Provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.

Smith & Nephew

Market Cap: UK£9.6b

Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.

Revvity

Market Cap: US$12.7b

Provides health sciences solutions, technologies, and services.

Axsome Therapeutics

Market Cap: US$12.6b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Penumbra

Market Cap: US$12.5b

Designs, develops, manufactures, and markets medical devices in the United States and internationally.

Elanco Animal Health

Market Cap: US$12.5b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Madrigal Pharmaceuticals

Market Cap: US$12.2b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Molina Healthcare

Market Cap: US$12.0b

Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.

Summit Therapeutics

Market Cap: US$12.0b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Arrowhead Pharmaceuticals

Market Cap: US$11.8b

Develops medicines for the treatment of intractable diseases in the United States.

Cytokinetics

Market Cap: US$11.7b

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States.

Baxter International

Market Cap: US$11.7b

Through its subsidiaries, provides a portfolio of healthcare products in the United States.

BioMarin Pharmaceutical

Market Cap: US$11.4b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Insulet

Market Cap: US$11.4b

Develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

Charles River Laboratories International

Market Cap: US$11.1b

Charles River Laboratories International, Inc.

Krystal Biotech

Market Cap: US$11.1b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Bio-Techne

Market Cap: US$11.0b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Globus Medical

Market Cap: US$10.9b

Develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Tempus AI

Market Cap: US$10.8b

Operates as a healthcare technology company in the United States.

Encompass Health

Market Cap: US$10.6b

Operates inpatient rehabilitation hospitals in the United States and Puerto Rico.

Apogee Therapeutics

Market Cap: US$10.0b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States.

ImmunityBio

Market Cap: US$9.9b

A biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases.

Henry Schein

Market Cap: US$9.8b

Provides health care products and services to office-based dental and medical practitioners worldwide.

Nuvalent

Market Cap: US$9.8b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Ensign Group

Market Cap: US$9.8b

Provides skilled nursing, senior living, and rehabilitative services.

Corcept Therapeutics

Market Cap: US$9.7b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Universal Health Services

Market Cap: US$9.6b

Through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States.